5-Amino-1MQ vs Cotadutide

Head-to-head comparison of 5-Amino-1MQ (5-Amino-1-methylquinolinium) and Cotadutide (MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

Property5-Amino-1MQCotadutide
CategoryWeight ManagementWeight Management
Full Name5-Amino-1-methylquinoliniumMEDI0382, long-acting GLP-1 and glucagon receptor dual agonist
Molecular Weight178.23 g/mol~4,700 Da
Half-Life~6 hoursApproximately 24 hours
Amino AcidsSmall molecule37
Typical Dose0.3-3 mg daily in clinical studies
RouteSubcutaneous
Purity>98%≥98%
Studies Count2818
Research StatusActive ResearchClinical

5-Amino-1MQ Benefits

  • Reduces body fat without appetite changes, lowers cholesterol, increases NAD+ levels, improves metabolic efficiency, supports cellular energy production

Cotadutide Benefits

  • body-weight reduction
  • improved insulin sensitivity
  • reduced hepatic fat
  • appetite suppression

5-Amino-1MQ Dosing

Research doses: 50-150 mg orally daily. Often cycled 8-12 weeks on, 4 weeks off. Best taken in the morning.

Cotadutide Dosing

Once-daily SC in trials|Start low and titrate based on tolerance|Monitor GI adverse effects

5-Amino-1MQ Side Effects

  • Generally well-tolerated in preclinical models. Potential mild GI discomfort and headache. Long-term human safety data is limited.

Cotadutide Side Effects

  • nausea
  • vomiting
  • diarrhea

Research Overview

5-Amino-1MQ

Studies in diet-induced obese mice showed significant reductions in body weight, white adipose tissue mass, and cholesterol levels without changes in food intake. Works by inhibiting NNMT enzyme to increase NAD+ and activate sirtuins.

Cotadutide

Phase 2 studies reported dose-dependent weight loss and favorable changes in glycemic and liver-related markers. It is one of the most cited synthetic dual-agonist peptides for obesity research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

5-Amino-1MQ stacks with:

AOD-9604MOTS-cCJC-1295

Cotadutide stacks with:

dietary-calorie-restrictionexercise-program
weight-lossNNMT-inhibitorfat-lossmetabolismNAD+GLP-1glucagon-coagonistdual-agonistobesity-research